Seagen
Patents, Design & Utilities
Last updated:
List of all Seagen patents 62 in total
| Status | Patent |
|---|---|
Application | Utility: DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODY Filling date: 5 Sep 2025 Issue date: 25 Aug 2022 |
Application | Utility: Glycan-Interacting Compounds and Methods of Use Filling date: 5 Sep 2025 Issue date: 18 Aug 2022 |
Application | Utility: DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES Filling date: 5 Sep 2025 Issue date: 11 Aug 2022 |
Grant | Utility: Anti-TIGIT antibodies Filling date: 5 Sep 2025 Issue date: 2 Aug 2022 |
Application | Utility: Masked Antibody Formulations Filling date: 5 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: CONJUGATES OF QUATERNIZED TUBULYSIN COMPOUNDS Filling date: 5 Sep 2025 Issue date: 21 Jul 2022 |
Application | Utility: METHODS OF REDUCING SIDE EFFECTS OF ANTI-CD30 ANTIBODY DRUG CONJUGATE THERAPY Filling date: 5 Sep 2025 Issue date: 21 Jul 2022 |
Grant | Utility: Process for the preparation of tubulysins and intermediates thereof Filling date: 5 Sep 2025 Issue date: 19 Jul 2022 |
Grant | Utility: Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates Filling date: 5 Sep 2025 Issue date: 28 Jun 2022 |
Application | Utility: CAMPTOTHECIN PEPTIDE CONJUGATES Filling date: 5 Sep 2025 Issue date: 23 Jun 2022 |
Application | Utility: METHODS OF TREATING BREAST CANCER WITH TUCATINIB Filling date: 5 Sep 2025 Issue date: 23 Jun 2022 |
Application | Utility: PHARMACEUTICAL COMPOSITIONS COMPRISING ANTI-191P4D12 ANTIBODY DRUG CONJUGATES AND METHODS OF USE THEREOF Filling date: 5 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: CYSTEINE MUTATED ANTIBODIES FOR CONJUGATION Filling date: 5 Sep 2025 Issue date: 9 Jun 2022 |
Grant | Utility: Anti-NTB-A antibodies and related compositions and methods Filling date: 5 Sep 2025 Issue date: 7 Jun 2022 |
Application | Utility: TREATMENT OF HER2 POSITIVE CANCERS Filling date: 5 Sep 2025 Issue date: 2 Jun 2022 |
Grant | Utility: CD19 binding agents and uses thereof Filling date: 5 Sep 2025 Issue date: 17 May 2022 |
Application | Utility: BETA-GLUCURONIDE-LINKER DRUG CONJUGATES Filling date: 5 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: CD47 Antibodies and Uses Thereof for Treating Cancer Filling date: 5 Sep 2025 Issue date: 5 May 2022 |
Grant | Utility: Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation Filling date: 5 Sep 2025 Issue date: 3 May 2022 |
Application | Utility: HUMANIZED ANTI-LIV1 ANTIBODIES FOR THE TREATMENT OF CANCER Filling date: 5 Sep 2025 Issue date: 14 Apr 2022 |
Grant | Utility: Humanized antibodies to LIV-1 and use of same to treat cancer Filling date: 5 Sep 2025 Issue date: 8 Mar 2022 |
Application | Utility: Methylene Carbamate Linkers for use with Targeted-Drug Conjugates Filling date: 5 Sep 2025 Issue date: 24 Feb 2022 |
Application | Utility: Glycan-Interacting Compounds and Methods of Use Filling date: 5 Sep 2025 Issue date: 24 Feb 2022 |
Grant | Utility: Glycan-interacting compounds and methods of use Filling date: 5 Sep 2025 Issue date: 22 Feb 2022 |
Application | Utility: ADCS WITH THIOL MULTIPLEX LINKERS Filling date: 5 Sep 2025 Issue date: 10 Feb 2022 |
Application | Utility: BCMA ANTIBODIES AND USE OF SAME TO TREAT CANCER AND IMMUNOLOGICAL DISORDERS Filling date: 5 Sep 2025 Issue date: 27 Jan 2022 |
Grant | Utility: Bivalent antibodies masked by coiled coils Filling date: 5 Sep 2025 Issue date: 25 Jan 2022 |
Grant | Utility: Dosage and administration of non-fucosylated anti-CD40 antibodies Filling date: 5 Sep 2025 Issue date: 4 Jan 2022 |
Grant | Utility: Treatment of HER2 positive cancers Filling date: 5 Sep 2025 Issue date: 28 Dec 2021 |
Grant | Utility: Dosage and administration of non-fucosylated anti-CD40 antibodies Filling date: 5 Sep 2025 Issue date: 21 Dec 2021 |
Grant | Utility: Combinations of PBD-based antibody drug conjugates with FLT3 inhibitors Filling date: 5 Sep 2025 Issue date: 7 Dec 2021 |
Application | Utility: GLYPICAN 3 ANTIBODIES AND CONJUGATES THEREOF Filling date: 5 Sep 2025 Issue date: 25 Nov 2021 |
Grant | Utility: CD47 antibodies and uses thereof for treating cancer Filling date: 5 Sep 2025 Issue date: 23 Nov 2021 |
Grant | Utility: Intact mass determination of protein conjugated agent compounds Filling date: 5 Sep 2025 Issue date: 9 Nov 2021 |
Application | Utility: ANTIBODIES TO INTEGRIN AVB6 AND USE OF SAME TO TREAT CANCER Filling date: 5 Sep 2025 Issue date: 4 Nov 2021 |
Application | Utility: WEEKLY DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJUGATES Filling date: 5 Sep 2025 Issue date: 14 Oct 2021 |
Application | Utility: SELF-STABILIZING LINKER CONJUGATES Filling date: 5 Sep 2025 Issue date: 30 Sep 2021 |
Application | Utility: HYDROPHILIC ANTIBODY-DRUG CONJUGATES Filling date: 5 Sep 2025 Issue date: 16 Sep 2021 |
Application | Utility: ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 191P4D12 PROTEINS Filling date: 5 Sep 2025 Issue date: 16 Sep 2021 |
Grant | Utility: Methylene carbamate linkers for use with targeted-drug conjugates Filling date: 5 Sep 2025 Issue date: 14 Sep 2021 |
Grant | Utility: Combination of CD33 antibody drug conjugates with chemotherapeutic agents Filling date: 5 Sep 2025 Issue date: 7 Sep 2021 |
Application | Utility: Anti-TIGIT Antibodies Filling date: 5 Sep 2025 Issue date: 2 Sep 2021 |
Grant | Utility: Pegylated drug-linkers for improved ligand-drug conjugate pharmacokinetics Filling date: 5 Sep 2025 Issue date: 31 Aug 2021 |
Application | Utility: METHODS OF INHIBITION OF PROTEIN FUCOSYLATION IN VIVO USING FUCOSE ANALOGS Filling date: 5 Sep 2025 Issue date: 26 Aug 2021 |
Grant | Utility: Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates Filling date: 5 Sep 2025 Issue date: 3 Aug 2021 |
Grant | Utility: BCMA antibodies and use of same to treat cancer and immunological disorders Filling date: 5 Sep 2025 Issue date: 3 Aug 2021 |
Application | Utility: Combination Therapy With LIV1-ADC and PD-1 Antagonist Filling date: 5 Sep 2025 Issue date: 29 Jul 2021 |
Application | Utility: METHODS OF TREATING CANCER WITH NONFUCOSYLATED ANTI-CD70 ANTIBODIES Filling date: 5 Sep 2025 Issue date: 22 Jul 2021 |
Application | Utility: ANTI-AVB6 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES Filling date: 5 Sep 2025 Issue date: 1 Jul 2021 |
Grant | Utility: Methods of inhibition of protein fucosylation in vivo using fucose analogs Filling date: 5 Sep 2025 Issue date: 15 Jun 2021 |
Showing 1 to 50 of 62 patents.